Search research articles
Contact Us
Filters
Showing results (61-70 of 131) with videos related to
Page
of 14
Sort By:
Ultrasound in Medicine & Biology
|
September 4, 2018
In Vivo Viscoelastic Response (VisR) Ultrasound for Characterizing Mechanical Anisotropy in Lower-Limb Skeletal Muscles of Boys with and without Duchenne Muscular Dystrophy
Christopher J Moore, Melissa C Caughey, Diane O Meyer, et al.
Frontiers in Public Health
|
September 28, 2023
The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges
Tom Hughes, James F Howard, Nicholas J Silvestri, et al.
European Journal of Neurology
|
October 7, 2024
Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis
Ali A Habib, Michael Benatar, Tuan Vu, et al.
NEJM Evidence
|
February 6, 2024
Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
Tuan Vu, Andreas Meisel, Renato Mantegazza, et al.
Neurology
|
November 24, 2020
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
Renato Mantegazza, Gil I Wolfe, Srikanth Muppidi, et al.
Neurology and Therapy
|
June 23, 2023
Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
Tuan Vu, Andreas Meisel, Renato Mantegazza, et al.
Muscle & Nerve
|
June 23, 2025
Pain Experiences and Prescription Pain Medications Among People With Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
Jonathan Suhl, Kristin M Conway, Shiny Thomas, et al.
Expert Opinion on Investigational Drugs
|
April 1, 2021
Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis
James F Howard, John Vissing, Nils E Gilhus, et al.
Journal of Neurology
|
February 24, 2024
Improvement of fatigue in generalised myasthenia gravis with zilucoplan
Michael D Weiss, Miriam Freimer, M Isabel Leite, et al.
Journal of Neuroimmunology
|
October 15, 2018
Circulating microRNA plasma profile in MuSK+ myasthenia gravis
Liis Sabre, Jeffrey T Guptill, Melissa Russo, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 131) with videos related to
Sort By:
Page
of 14
Ultrasound in Medicine & Biology
|
September 4, 2018
In Vivo Viscoelastic Response (VisR) Ultrasound for Characterizing Mechanical Anisotropy in Lower-Limb Skeletal Muscles of Boys with and without Duchenne Muscular Dystrophy
Christopher J Moore, Melissa C Caughey, Diane O Meyer, et al.
Frontiers in Public Health
|
September 28, 2023
The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges
Tom Hughes, James F Howard, Nicholas J Silvestri, et al.
European Journal of Neurology
|
October 7, 2024
Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis
Ali A Habib, Michael Benatar, Tuan Vu, et al.
NEJM Evidence
|
February 6, 2024
Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
Tuan Vu, Andreas Meisel, Renato Mantegazza, et al.
Neurology
|
November 24, 2020
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
Renato Mantegazza, Gil I Wolfe, Srikanth Muppidi, et al.
Neurology and Therapy
|
June 23, 2023
Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
Tuan Vu, Andreas Meisel, Renato Mantegazza, et al.
Muscle & Nerve
|
June 23, 2025
Pain Experiences and Prescription Pain Medications Among People With Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
Jonathan Suhl, Kristin M Conway, Shiny Thomas, et al.
Expert Opinion on Investigational Drugs
|
April 1, 2021
Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis
James F Howard, John Vissing, Nils E Gilhus, et al.
Journal of Neurology
|
February 24, 2024
Improvement of fatigue in generalised myasthenia gravis with zilucoplan
Michael D Weiss, Miriam Freimer, M Isabel Leite, et al.
Journal of Neuroimmunology
|
October 15, 2018
Circulating microRNA plasma profile in MuSK+ myasthenia gravis
Liis Sabre, Jeffrey T Guptill, Melissa Russo, et al.
Page
of 14